Search results
New drug for cervical cancer patients approved for use in NHS in Scotland
Press Association News via AOL· 1 year agoScotland has become the the first part of the UK to make a new treatment for women with advanced...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?
Investor's Business Daily· 1 year agoIn the span of a month in late 2022, Merck gained a new chairman, announced a $1.35 billion takeover...
New Skin Cancer Vaccine Cuts Risk of Relapse by 44%, Study Shows—Here’s What to Know
Prevention via AOL· 1 year agoA new vaccine has shown promise in reducing the risk of developing skin cancer. Phase 2 clinical...
Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up
Investor's Business Daily· 2 years agoModerna stock broke out Tuesday after the company said adding its personalized cancer vaccine to...
Merck (MRK) Gets FDA Nod for Keytruda Expansion in Gastric Cancer
Zacks via Yahoo Finance· 7 months agoFollowing this approval, Merck's (MRK) Keytruda is approved for seven gastrointestinal cancers....
FDA approves new Bristol Myers drug for lung cancer
BioPharma Dive via Yahoo Finance· 7 months agoAcquired via a $4 billion biotech buyout, Augtyro is one of an array of new products the pharma hopes will offset patent expirations for current top...
Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use
Zacks via Yahoo Finance· 5 months agoFDA approves Merck's (MRK) Keytruda plus chemoradiotherapy (CRT) for patients with FIGO 2014 Stage...
Merck's lung cancer drug combo fails trial in setback for new therapy class
Reuters via AOL· 6 months agoMerck's experimental anti-TIGIT drug vibostolimab in combination with its approved therapy Keytruda...
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters via AOL· 1 month agoThis is the latest setback for the experimental drug, vibostolimab, and the related promising new...